Daniel Swisher
Chairman bei CERUS CORPORATION
Vermögen: 7 Mio $ am 31.03.2024
Profil
Daniel N. Swisher ist President & Chief Operating Officer bei Jazz Pharmaceuticals Plc, President & Chief Operating Officer bei Jazz Pharmaceuticals, Inc. und unabhängiger Direktor bei Corcept Therapeutics, Inc. sowie Chairman bei Cerus Corp. Er ist Mitglied des Board of Directors bei Corcept Therapeutics, Inc. Herr Swisher war zuvor als President, CEO, Secretary & Director bei Sunesis Pharmaceuticals, Inc. und als Senior Vice President-Sales & Marketing bei ALZA Corp. beschäftigt. Er erhielt seinen Bachelor-Abschluss von der Yale University und einen MBA von der Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2023 | 55 014 ( 0,09% ) | 7 Mio $ | 31.03.2024 | |
CERUS CORPORATION
0,06% | 07.06.2023 | 104 545 ( 0,06% ) | 197 590 $ | 31.03.2024 |
| 26.10.2023 | 0 ( -.--% ) | - $ | 31.03.2024 | |
| 01.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Daniel Swisher
| Unternehmen | Position | Beginn |
|---|---|---|
| CERUS CORPORATION | Chairman | 01.10.2013 |
| CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 18.06.2015 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 26.10.2023 |
Ehemalige bekannte Positionen von Daniel Swisher
| Unternehmen | Position | Ende |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | President | 01.10.2023 |
| VIRACTA THERAPEUTICS, INC. | Chief Executive Officer | 31.12.2017 |
| ALZA CORPORATION | Sales & Marketing | 01.09.2001 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | President | - |
Ausbildung von Daniel Swisher
| Yale University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| CERUS CORPORATION | Health Technology |
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
